Canlyniadau Chwilio - Carl D. Regillo

Mireinio'r Canlyniadau
  1. 1
    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration

    Baseline Predictors of 12-Month Treatment Response to Ranibizumab in Patients With Wet Age-Related Macular Degeneration gan Carl D. Regillo, Brandon Busbee, Allen C. Ho, Beiying Ding, Zdenka Hašková

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration

    Long-term (60-month) results for the implantable miniature telescope: efficacy and safety outcomes stratified by age in patients with end-stage age-related macular degeneration gan David S. Boyer, K. Bailey Freund, Carl D. Regillo, Marc H. Levy, Sumit Garg

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials

    Predictors of Diabetic Macular Edema Treatment Frequency with Ranibizumab During the Open-Label Extension of the RIDE and RISE Trials gan Charles C. Wykoff, Michael J. Elman, Carl D. Regillo, Beiying Ding, Na Lu, Ivaylo Stoilov

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System

    Economic Evaluation of a Home-Based Age-Related Macular Degeneration Monitoring System gan John S. Wittenborn, Traci E. Clemons, Carl D. Regillo, Nadim Rayess, Danielle Kruger, David B. Rein

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration

    Twenty-four-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-Related Macular Degeneration gan Allen C. Ho, Brandon Busbee, Carl D. Regillo, Mark R. Wieland, Sherri A. Van Everen, Zhengrong Li, Roman G. Rubio, Phillip Lai

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic

    Clinical Presentation of Rhegmatogenous Retinal Detachment during the COVID-19 Pandemic gan Luv Patel, Travis Peck, Matthew R. Starr, Michael J. Ammar, Khan Ma, Yoshihiro Yonekawa, Michael A. Klufas, Carl D. Regillo, Allen C. Ho, David Xu

    Cyhoeddwyd 2020
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION

    ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION gan Anton Orlin, Dexter Hadley, Woohyok Chang, Allen C. Ho, Gary C. Brown, Richard Kaiser, Carl D. Regillo, Ashlee N. Godshalk, Audun Lier, Brian Kaderli, Dwight Stambolian

    Cyhoeddwyd 2011
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor

    Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti–Vascular Endothelial Growth Factor gan Anthony Obeid, Daniel Su, Samir Patel, Joshua H. Uhr, Durga S. Borkar, Xinxiao Gao, Mitchell S. Fineman, Carl D. Regillo, Joseph I. Maguire, Sunir J. Garg, Jason Hsu

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study

    Safety and efficacy of ixoberogene soroparvovec in neovascular age-related macular degeneration in the United States (OPTIC): a prospective, two-year, multicentre phase 1 study gan Arshad M. Khanani, David S. Boyer, Charles C. Wykoff, Carl D. Regillo, Brandon Busbee, Dante J. Pieramici, Carl J. Danzig, Brian C. Joondeph, James C. Major, Adam Turpcu, Szilárd Kiss

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Juxtapapillary capillary hemangiomas

    Juxtapapillary capillary hemangiomas gan Cathleen M. McCabe, Harry W. Flynn, Carol L Shields, Jerry A. Shields, Carl D Regillo, H. Richard McDonald, María H. Berrocal, J. Donald M. Gass, William F. Mieler

    Cyhoeddwyd 2000
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Sustained Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials gan Gui‐shuang Ying, Benjamin J. Kim, Maureen G. Maguire, Jiayan Huang, Ebenezer Daniel, Glenn J. Jaffe, Juan E. Grunwald, Kevin J. Blinder, Christina J. Flaxel, Firas M. Rahhal, Carl D. Regillo, Daniel Martín

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES

    TREAT-AND-EXTEND REGIMENS WITH ANTI-VEGF AGENTS IN RETINAL DISEASES gan K. Bailey Freund, Jean‐François Korobelnik, Robert G. Devenyi, Carsten Framme, John Galic, Edward N. Herbert, Hans Hoerauf, Paolo Lanzetta, Stephan Michels, Paul Mitchell, Jordi Monés, Carl D. Regillo, Ramin Tadayoni, James Talks, Sebastián Wolf

    Cyhoeddwyd 2015
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema

    KESTREL and KITE Phase 3 Studies: 100-Week Results With Brolucizumab in Patients With Diabetic Macular Edema gan Charles C. Wykoff, Justus G. Garweg, Carl D. Regillo, Eric H. Souied, Sebastián Wolf, Dilsher S. Dhoot, Hansjuergen Agostini, Andrew Chang, Augustinus Laude, J Wachtlin, Lidija Kovacic, Lixin Wang, Ying Wang, Emmanuel Bouillaud, David M. Brown

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

    The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration gan Peter A. Campochiaro, Dennis M. Marcus, Carl C. Awh, Carl D. Regillo, Anthony P. Adamis, Vladimir Bantseev, Ya‐Wen Chiang, Jason S. Ehrlich, Signe Erickson, William D. Hanley, Joshua Horvath, Katie F. Maass, Natasha Singh, Fan Tang, Giulio Barteselli

    Cyhoeddwyd 2019
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections

    Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections gan Samir Patel, Raziyeh Mahmoudzadeh, Mirataollah Salabati, Rebecca R. Soares, John W. Hinkle, Jason Hsu, Sunir J. Garg, Carl D. Regillo, Allen C. Ho, Michael N. Cohen, Khan Ma, Yoshihiro Yonekawa, Allen Chiang, Omesh P. Gupta, Ajay E. Kuriyan

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration

    Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration gan Brian L. Yaspan, David F. Williams, Frank G. Holz, Carl D. Regillo, Zhengrong Li, Amy Dressen, Menno van Lookeren Campagne, Kha Le, Robert Graham, Tatiana Beres, Tushar Bhangale, Lee Honigberg, Ashley Smith, Erin C. Henry, Carole Ho, Erich C. Strauss

    Cyhoeddwyd 2017
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Primary Retinal Detachment Outcomes Study Report Number 2

    Primary Retinal Detachment Outcomes Study Report Number 2 gan Edwin H. Ryan, Claire Ryan, Nora J. Forbes, Yoshihiro Yonekawa, Sushant Wagley, Robert A. Mittra, D. Wilkin Parke, Daniel P. Joseph, Geoffrey G. Emerson, Gaurav K. Shah, Kevin J. Blinder, Antonio Capone, George A. Williams, Dean Eliott, Omesh P. Gupta, Jason Hsu, Carl D. Regillo

    Cyhoeddwyd 2020
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Artificial Intelligence Detection of Diabetic Retinopathy

    Artificial Intelligence Detection of Diabetic Retinopathy gan Jennifer I. Lim, Carl D. Regillo, Srinivas R. Sadda, Eli Ipp, Malavika Bhaskaranand, Chaithanya Ramachandra, Kaushal Solanki, Harvey Dubiner, Grace A. Levy-Clarke, Richard D. Pesavento, Mark D. Sherman, Steven Silverstein, Brian Kim, Gerald B. Walman, Barbara A. Blodi, Amitha Domalpally, Susan Reed, James Reimers, Kris Lang, Holy Cohn, Ruth Shaw, Sheila Watson, Andrew Ewen, Nancy Barrett, Maria Swift, Jeffrey Gornbein

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial

    Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial gan Lyndon da Cruz, Jessy D. Dorn, Mark S. Humayun, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Allen C. Ho, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Robert J. Greenberg

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind

    Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind gan Allen C. Ho, Mark S. Humayun, Jessy D. Dorn, Lyndon da Cruz, Gislin Dagnelie, James T. Handa, Pierre‐Olivier Barale, José‐Alain Sahel, Paulo Stanga, Farhad Hafezi, Avinoam B. Safran, Joël Salzmann, Arturo Santos, David G. Birch, Rand Spencer, Artur V. Cideciyan, Eugene de Juan, Jacque L. Duncan, Dean Eliott, Amani A. Fawzi, Lisa C. Olmos de Koo, Gary C. Brown, Julia A. Haller, Carl D. Regillo, Lucian V. Del Priore, Aries Arditi, Duane R. Geruschat, Robert J. Greenberg

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: